Objective: Little is known about the gonadal function of boys conceived by intracytoplasmic sperm injection (ICSI) from fathers with compromised spermatogenesis. To evaluate the potential risk of tubular dysfunction in these boys, we assessed morphological and functional gonadal parameters and their correlation with paternal sperm characteristics. Study Design: In a group of 88 eight-year-old ICSI boys, we measured testicular and penile size. Serum concentrations of anti-mullerian hormone (AMH) and inhibin B were analyzed in 59 of them. Results: Except for two boys with micropenis, penis length and mean testicular length were normal in all boys. In 7 boys inhibin B concentrations were below the lower limit for age, while all AMH results were within normal limits. Serum Sertoli cell markers correlated significantly with each other (p < 0.005), but were independent of paternal sperm parameters. Conclusion: Our data suggest that penile and testicular growth as well as Sertoli cell function are normal in the majority of prepubertal ICSI boys. Serum AMH and inhibin B levels were found to be independent of sperm quality of the father. Further follow-up of these prepubertal children is needed to examine whether normal Sertoli cell markers will be followed by a normal spermatogenesis in puberty.

1.
Budde WJ, Verjaal M, Hamerlynck JV, Bobrow M: Familial occurrence of azoospermia and extreme oligozoospermia. Clin Genet 1984;26:555–562.
2.
Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A: Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002;17:2600–2614.
3.
Kallen B, Finnstrom O, Nygren KG, Olausson PO: In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects Res [A] 2005;73:162–169.
4.
Mau Kai C, Main KM, Andersen AN, Loft A, Skakkebæk NE, Juul A: Reduced serum testosterone levels in infant boys conceived by intracytoplasmic sperm injection. J Clin Endocrinol Metab 2007;92:2598–2603.
5.
Bonduelle M, Wennerholm UB, Loft A, Tarlatzis BC, Peters C, Henriet S, et al: A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod 2005;20:413–419.
6.
Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ: Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol 2002;56:215–221.
7.
Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, et al: Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003;211:55–63.
8.
Belva F, Henriet S, Liebaers I, Van Steirteghem A, Celestin-Westreich S, Bonduelle M: Medical outcome of 8-year-old singleton ICSI children (born > or = 32 weeks’ gestation) and a spontaneously conceived comparison group. Hum Reprod 2007;22:506–515.
9.
Prader A: Recognizable Patterns of Human Malformation, ed 3. Philadelphia, Saunders, 1985.
10.
Damon V, Berlier P, Durozier B, François R: Study of the dimensions of the penis from birth to adult age and as a function of testicular volume. Pediatrie 1990;45:519–522.
11.
Zilka E, Laron Z: The normal testicular volume in Israeli children and adolescents. Harefuah 1969;77:511–113.
12.
Nistal M, Abaurrea MA, Paniagua R: Morphological and histometric study on the human Sertoli cell from birth to the onset of puberty. J Anat 1982;134:351–363.
13.
Chemes HE: Infancy is not a quiescent period of testicular development. Int J Androl 2001;24:2–7.
14.
Cicognani A, Alessandroni R, Pasini A, et al: Low birth weight for gestational age and subsequent male gonadal function. J Pediatr 2002;141:376–379.
15.
Bonduelle M, Liebaers I, Deketelaere V, et al: Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 2002;17:671–694.
16.
Kubini K, Zachmann M, Albers N, et al: Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000;85:134–138.
17.
Radicioni AF, Anzuini A, De Marco E, Nofroni I, Castracane VD, Lenzi A: Changes in serum inhibin B during normal male puberty. Eur J Endocrinol 2005;152:403–409.
18.
Anawalt BD, Bebb RA, Matsumoto AM, et al: Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341–3345.
19.
Orth JM, Gunsalus GL, Lamperti AA: Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 1988;122:787–794.
20.
Rey R: Assessment of seminiferous tubule function (anti-mullerian hormone). Baillières Best Pract Res Clin Endocrinol Metab 2000;14:399–408.
21.
Lahlou N, Fennoy I, Carel JC, Roger M: Inhibin B and anti-müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol Metab 2004;89:1864–1868.
22.
Christiansen P, Andersson AM, Skakkebæk NE: Longitudinal studies of inhibin B levels in boys and young adults with Klinefelter syndrome. J Clin Endocrinol Metab 2003;88:888–891.
23.
Andersson AM, Skakkebæk NE: Serum inhibin B levels during male childhood and puberty. Mol Cell Endocrinol 2001;180:103–107.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.